Dr. DeGowin's clinical interests include the care and study of patients with hematologic malignancies, anemial, hemopoietic insufficiency, myeloproliferative diseases, and problems with hemostasis. Laboratory investigation in the field of experimental hematology has involved studies of hemopoietic stem cell proliferation and differentiation. He has studied the hemopoietic abnormalities to explain the hemopoietic insufficiency in patients with cancer and/or infection who receive radiation therapy of antineoplastic chemotherapeutic agents. He has found that either tumor-bearing or chronic inflammation profoundly impairs survival and suppresses hemopoitic recovery of mice after sublethal total-body irradiation. Clinical studies have demonstrated the efficacy and safety of recombinant erythropoietin administered to predialysis patients with chronic renal failure.

Honors, Awards, and Organizations

• Alpha Omega Alpha
• American Association for Cancer Research
• Diplomate, American Board of Internal Medicine and Board of Hematology
• American College of Physicians, Fellow
• American College of Physicians, Iowa Laureate Award
• American Federation for Clinical Research Chairman, Membership Committee, 1974, 1975
• Central Society for Clinical Research
• International Society for Experimental Hematology
• International Society of Hematology
• Radiation Research Society
• Society for Experimental Biology and Medicine

Medical School:
University of Chicago

Residency:
University of Chicago

Fellowship:
Argonne Cancer Research Hospital

Special Training:
University of Chicago, Army Medical Research Project